Feasibility of adjuvant chemotherapy with doxorubicin plus docetaxel followed by sequential capecitabine in patients with node positive breast cancer.

被引：0
|
作者：
Lara, R
Mayordomo, JI
Modolell, A
Burillo, M
Sanz, J
Murillo, L
Janariz, J
Perez, V
Andres, R
Tres, A
机构：
[1] Hosp Clin Univ, Zaragoza, Spain
[2] Inst Oncol Corachan, Barcelona, Spain
[3] Hosp San Jorge, Huesca, Spain
[4] Hosp Tudela, Tudela, Spain
[5] Hosp Creu Roja De Barcelona, Barcelona, Spain
[6] Hosp Arritxaca, Murcia, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
782
引用
收藏
页码：72S / 72S
页数：1
相关论文
共 50 条
  • [31] A phase II study of adjuvant chemotherapy with sequential doxorubicin-cyclophosphamide (AC) and docetaxel followed by radiotherapy in patients with high-risk early breast cancer. A trial of the Pakistan Cancer Research Group
    Khan, Shaharyar
    Shah, Ijaz H.
    Shahid, Abubaker
    Hafeez, Muhammed
    Perveen, Shaheena
    Javed, Abrar A.
    Masood, Ahmed I.
    ANNALS OF ONCOLOGY, 2004, 15 : 66 - 67
  • [32] Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer
    Wenzel, C
    Bartsch, R
    Locker, GJ
    Hussian, D
    Pluschnig, U
    Sevelda, U
    Gnant, MF
    Jakesz, R
    Zielinski, CC
    Steger, GG
    ANTI-CANCER DRUGS, 2005, 16 (04) : 441 - 445
  • [33] Feasibility Study of Docetaxel with Cyclophosphamide as Adjuvant Chemotherapy for Japanese Breast Cancer Patients
    Takabatake, Daisuke
    Taira, Naruto
    Hara, Fumikata
    Sien, Tadahiko
    Kiyoto, Sachiko
    Takashima, Seiki
    Aogi, Kenjiro
    Ohsumi, Shozo
    Doihara, Hiroyoshi
    Takashima, Shigemitu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (08) : 478 - 483
  • [34] A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer
    Di Leo, A
    Crown, J
    Nogaret, JM
    Duffy, K
    Bartholomeus, S
    Dolci, S
    Rowan, S
    O'Higgins, N
    Paesmans, M
    Larsimont, D
    Riva, A
    Piccart, MJ
    ANNALS OF ONCOLOGY, 2000, 11 (02) : 169 - 175
  • [35] Phase II study of sequential administration of vinorelbine-capecitabine combination followed by weekly docetaxel as first line chemotherapy for advanced breast cancer.
    Ghosn, M
    Chahine, G
    Kattan, J
    Farhat, F
    Nasr, F
    Moukaddem, W
    Tueni, E
    Dagher, J
    Younes, F
    Gasmi, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 80S - 80S
  • [36] Comparison of Doxorubicin Plus Docetaxel Neoadjuvant Chemotherapy with Doxorubicin Plus Vinorelbine in Primary Breast Cancer
    Gwak, Geumhee
    Kim, Ji-Young
    Park, Keongmee
    Shin, Young Joo
    Cho, Hyunjin
    Park, Sung Jin
    Yang, Geun Ho
    Bae, Byung Noe
    Kim, Ki Whan
    Han, Sehwan
    JOURNAL OF BREAST CANCER, 2011, 14 (02) : 129 - 134
  • [37] E2197: Phase III AT (doxorubicin/docetaxel) vs. AC (doxorubicin/cyclophosphamide) in the adjuvant treatment of node positive and high risk node negative breast cancer.
    Goldstein, LJ
    O'Neill, A
    Sparano, J
    Perez, E
    Shulman, L
    Martino, S
    Davidson, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 7S - 7S
  • [38] Cbcsg-10: Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for triple negative breast cancer.
    Shao Zhimin
    Li, Junjie
    Pang, Da
    Wang, Changqing
    Jiang, Jun
    Yang, Suisheng
    Liu, Yunjiang
    Fu, Pei Fen
    Sheng, Yuan
    Zhang, Guojun
    Cao, Liya
    He, Qi
    Cul, Shude
    Wang, Xijing
    Ren, Guosheng
    Li, Xinzheng
    Yu, Shiyou
    Liu, Pengxi
    Xu, Binghe
    Hu, Xi-Chun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Sequential chemotherapy with gemcitabine plus carboplatin, followed by additional docetaxel for aged patients with advanced upper-tract urothelial cancer.
    Yoneyama, Takahiro
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yamamoto, Hayato
    Imai, Atsushi
    Mori, Kazuyuki
    Hatakeyama, Shingo
    Hashimoto, Yasuhiro
    Koie, Takuya
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [40] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with stage II/IIIA breast cancer
    Iacobelli, S.
    Cianchetti, E.
    Ficorella, C.
    Angelucci, D.
    Grossi, S.
    Noccioli, P.
    Ricevuto, E.
    Rispoli, A.
    Castrilli, G.
    Grassadonia, A.
    Zilli, M.
    Tinari, N.
    Di Giacobbe, A.
    Natoli, C.
    ANNALS OF ONCOLOGY, 2006, 17 : XI5 - XI6
12345